Video

CURE New Issue Alert: 2020 Hematology Special Edition-1

Here are the latest highlights from the first CURE Hematology Special Edition issue for 2020.

Hi, I’m Jessica Skarzynski for CURE Magazine®, your guide to every stage of the cancer experience.

Here’s a look at what’s inside our 2020 Winter Hematology special issue:

For decades the treatment for acute myeloid leukemia remained the same — intensive chemotherapy. But a wave of new targeted therapies in recent years have expanded options for patients while helping them live longer and better lives. We delve into how oncologists are changing up therapy by Making It Personal.

Next, Eyes are on Immunotherapy for patients with relapsed and resistant diffuse large B-cell lymphoma. Our feature story discusses new treatments beyond tried-and-true chemotherapy.

To read these stories and more, visit our publications here and click on the latest CURE cover.

Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit here for more information.

And, as always, thanks for reading.

Related Videos
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Image of man with black hair.
Image of doctor with grey hair.
Image of doctor with black hair.
Dr. Alan Tan is a genitourinary oncology (GU) and melanoma specialist at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee; an associate professor of medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center; and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.